Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 3Adenocarcinoma of Lung 3Squamous Cell Carcinoma of Head and Neck 2Mouth Neoplasms 2Lung Neoplasms 2Head and Neck Neoplasms 2Barrett Esophagus 2Thyroid Neoplasms 1Thyroid Cancer, Papillary 1Skin Neoplasms 1Salivary Gland Neoplasms 1Oropharyngeal Neoplasms 1Laryngeal Neoplasms 1Esthesioneuroblastoma, Olfactory 1Esophageal Neoplasms 1Carcinoma, Basal Cell 1Adenocarcinoma, Follicular 1

Interventions

Photochemotherapy 41-phenyl-3,3-dimethyltriazene 4sonidegib 2pembrolizumab 2HhAntag691 2Biopsy 2tozuleristide 1tocilizumab 1talimogene laherparepvec 1silmitasertib 1prednylidene 1poly ICLC 1flt3 ligand protein 1deltacortene 1cemiplimab 1Tacrolimus 1TAK-441 1Sirolimus 1SUB1 protein, human 1Radiotherapy 1Radiation 1Prednisone 1Nivolumab 1NVP-LEQ506 1Microarray Analysis 1Mass Spectrometry 1Laser Therapy 1Ipilimumab 1Imiquimod 1Glatiramer Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Carcinoma, Basal Cell × 2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a × Clear all
NCT00017485 2011-03-07

Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer

Roswell Park Cancer Institute

Phase 1 Completed
6 enrolled
Dermatologic

Carcinoma, Basal Cell, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡